Transforming global health demands smart chemistry, addressing urgent health challenges through innovative, durable medical ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

Asia Pacific artificial organ and bionics market will grow by 10.2% annually with a total addressable market cap of $133.85 billion over 2023-2032. The growth is driven by a rising incidence of organ ...

Europe artificial organ and bionics market was valued at $7.86 billion in 2022 and will grow by 8.0% annually over 2022-2032. The growth is driven by a rising incidence of organ failure due to ...

"Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing" was originally created and published by Medical ...

Thanks to a new technology called Moscot ("Multi-Omics Single-Cell Optimal Transport"), researchers can now observe millions of cells simultaneously as they develop into a new organ-for example, a ...

Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its ...

Artificial sweeteners can be a healthy way to add sweetness without sugar, but not all sugar substitutes are created equal. Some artificial sweeteners offer sweetness without introducing unwanted ...